Mushroom Supplement Transparency: Why Standardization Disclosures Matter

Published June 2026 · Pilly Labs Editorial

Here is a thought experiment. Imagine walking into a restaurant where the menu lists "Chef's Special Protein Plate" but refuses to tell you what protein is on the plate, how much of it there is, where it came from, or how it was prepared. You would leave. You would not pay money for a meal that withholds the most basic information about what you are eating.

Now look at the mushroom supplement aisle. A significant percentage of products tell you almost nothing about what is actually inside the capsule. They list ingredient names without amounts. They use "proprietary blend" to legally obscure their formulas. They omit extract type, concentration ratio, and standardization data. And they charge you full price for the privilege of not knowing what you bought.

The supplement industry has a transparency problem, and it is not an accident. It is a business model. This article explains what transparency looks like, why it matters for your purchasing decisions, and what specific disclosures you should demand from any mushroom supplement brand.

The Proprietary Blend Problem

Under current FDA labeling rules, supplement manufacturers are allowed to list a group of ingredients under a single "proprietary blend" heading with only a combined total weight. The individual amounts of each ingredient within the blend do not need to be disclosed. The ingredients must be listed in descending order by weight, but without actual numbers, "descending order" tells you almost nothing useful.

Consider a hypothetical label:

This label is FDA-compliant. It is also nearly useless. That 500mg could be distributed evenly (about 83mg each) or it could be 450mg of cheap Reishi powder and 10mg each of everything else. The manufacturer knows. You do not. And because the formula is "proprietary," you have no legal right to find out.

The stated justification for proprietary blends is intellectual property protection — brands argue they need to prevent competitors from copying their exact formulas. In practice, the mushroom supplement category does not involve novel compounds or groundbreaking formulation science. The "proprietary" aspect of most blends is not protecting innovation. It is protecting margins. It costs less to put 450mg of one cheap ingredient and 10mg of five expensive ones than to include meaningful amounts of all six. The proprietary blend label makes this invisible.

What Standardization Tells You (and What Its Absence Tells You)

Standardization is the practice of testing an extract and verifying that it contains a minimum concentration of a specific bioactive compound — typically polysaccharides or beta-glucans in mushroom supplements. When a label says "standardized to 40% polysaccharides," it means the manufacturer invested in analytical testing, confirmed the bioactive content meets a threshold, and is willing to put that number on the label where it can be verified.

Standardization data is a transparency signal for three reasons:

1. It confirms the extract was actually tested. Analytical testing costs money. A brand that discloses standardization data has invested in quality verification. A brand that omits it may not have tested the product at all.
2. It gives you a comparable metric. "Chaga 1,000mg standardized to 40% polysaccharides" can be directly compared to another product's specifications. "Chaga 1,000mg" alone cannot — because you do not know what that 1,000mg actually contains.
3. It holds the manufacturer accountable. A stated standardization percentage is a testable claim. If a product says 40% polysaccharides, an independent lab can verify that number. Accountability disappears when no numbers are given.

The absence of standardization data does not always mean a product is low quality. But it does mean you are trusting the brand with no way to verify that trust. In a market where quality varies enormously, that is a significant ask.

Extract Type: The Disclosure That Changes Everything

Whether a mushroom supplement uses fruiting body extracts or mycelium-on-grain is arguably the single most important quality factor in the category. Independent analyses have repeatedly shown that fruiting body extracts contain dramatically higher concentrations of beta-glucans — the primary bioactive polysaccharides — compared to mycelium-on-grain products, which can contain substantial amounts of grain starch.¹

Transparent brands clearly state "fruiting body extract" on their labels. They do this because it is a competitive advantage and because consumers deserve to know what part of the organism they are consuming. Brands that omit this information are, in most cases, using mycelium-on-grain — because if they were using fruiting body, they would say so.

Extract ratio disclosure (e.g., 10:1) adds another layer of useful information. It tells you how concentrated the extract is relative to raw material. A 10:1 extract means 10 kilograms of raw mushroom were concentrated into 1 kilogram of extract. Higher ratios generally mean more concentrated bioactive compounds per milligram of finished product.

Third-Party Testing: Trust but Verify

The supplement industry in the United States is self-regulated under DSHEA (the Dietary Supplement Health and Education Act of 1994). Products do not require FDA pre-approval before going to market. This regulatory framework places the burden of quality on the manufacturer — and that burden is only meaningful if it is backed by independent verification.

Third-party testing means an independent laboratory — not affiliated with the manufacturer — has tested the finished product for:

• Identity: Is the product actually what the label says it is?
• Potency: Does the bioactive content match the label claim?
• Contaminants: Are heavy metals, pesticides, and microbial contamination within acceptable limits?

The results of this testing should be documented in a Certificate of Analysis (COA). Brands that invest in third-party testing generally make COAs available upon request or publish them on their website. The willingness to share test results is itself a transparency signal. Reluctance to share them is a signal too.

What Full Transparency Looks Like in Practice

A fully transparent mushroom supplement label should tell you:

1. Every mushroom species in the product, individually listed.
2. The per-serving amount of each species in milligrams — no proprietary blend totals.
3. Whether the product uses fruiting body or mycelium.
4. The extract ratio (e.g., 10:1).
5. Standardization data (e.g., polysaccharide or beta-glucan percentage) where applicable.
6. Confirmation of third-party testing, with COAs available.
7. Organic certification status.

That is seven disclosures. None of them are proprietary. None of them compromise intellectual property. All of them help you make an informed decision. And a disheartening number of products in the mushroom supplement market fail on four or more of these seven points.

How Pilly Labs Approaches Transparency

We will hold ourselves to the same rubric:

The Pilly Labs Mushroom Gummies 10-Blend individually lists all 10 mushroom species with per-serving amounts. Fruiting body extracts. 10:1 extract ratio. No proprietary blend. Third-party tested.

The Pilly Labs Chaga Mushroom Capsules disclose a 1,000mg per-serving dose, standardized to 40% polysaccharides. Organic certified. Third-party tested with COAs available.

We designed our products this way because we believe the supplement industry's transparency problem is not just an ethical issue — it is a market failure. Consumers cannot make rational choices without adequate information. Proprietary blends, undisclosed extract types, and missing standardization data are not competitive strategies. They are information asymmetries that exploit consumer trust.

We would rather compete on the merits of what is inside our products than on the opacity of our labels. Every brand in this category should have to make that same choice.

References

1. McCleary BV, Draga A. Measurement of Beta-Glucan in Mushrooms and Mycelial Products. J AOAC Int. 2016;99(2):364-373. See also: Nammex Analytical Laboratory comparative reports on commercial mushroom supplement beta-glucan content, 2017-2022.